Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.

BMC Cardiovasc Disord · 2015 · PMC4599328 · PMID 26450578

Europe PMC DOI

hedged sentence

0.0060

closest p · 0.1× alpha

0.0060

boldest claim

The sentences

highly significantP < 0.006actually significant

which included 23 % of diabetic patients treated with TAPT and 28 % treated with DAPT showed that cilostazol-treated patients with oral hypoglycemic medications experienced a highly significant 63 % reduction in the risk of restenosis ( P < 0.006) [ 21 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.